Results 111 to 120 of about 66,840 (318)

Early-life exposure to Ivermectin alters long-term growth and disease susceptibility.

PLoS ONE, 2021
Ivermectin is a broad-spectrum antiparasitic medicine, which is often used as a treatment for parasites or as a prophylaxis. While studies have looked at the long-term effects of Ivermectin on helminths, studies have not considered the long-term impacts ...
Taegan A McMahon, Shannon Fernandez-Denmark, Jeffrey M Grim   +2 more
doaj   +1 more source

Ivermectin as a possible treatment for COVID-19: a review of the 2022 protocols [PDF]

, 2022
Leila Larisa Medeiros Marques, Stéphani Caroline Beneti, C. Pinzon, Flávia Aparecida Reitz Cardoso   +3 more
openalex   +1 more source

An empirical method to estimate the effect of soil on the rate for transmission of damping‐off disease

, 2004
The ability of some soils to suppress soil-borne diseases has been long recognised, but the underlying epidemiological mechanisms by which this occurs are largely unknown.• Using damping-off disease caused by Rhizoctonia solani, spreading through ...
Alabouvette C, Bailey DJ, C. A. Gilligan, Cook RJ, Dwyer G, Garrett KA, Gilligan CA, Gilligan CA, Gilligan CA, Hoper H, J. A. N. Filipe, Jeger MJ, Kleczkowski A, Nisbet RM, Otten W, Pielaat A, van den Bosch F, Van der Plank JE, W. Otten, Whipps JM   +19 more
core   +1 more source

Physiological and behavioural effects of continuous remifentanil‐xylazine administration in donkeys

Equine Veterinary Journal, EarlyView.
Abstract Background Remifentanil and xylazine are used as continuous infusions to facilitate standing surgery in horses. Their use for this purpose has not been reported in donkeys. Objectives To evaluate the behavioural, sedative, and cardiorespiratory effects of continuous intravenous infusion of remifentanil and xylazine in donkeys. Study Design Non‐
Kássia Fernanda Araújo Damasceno, Andressa Nunes Mouta, Larissa de Sant' Ana Alves, Kathryn Nóbrega Arcoverde, Herbert Reis Aragão, Jerson Marques Cavalcante, Valéria Veras de Paula   +6 more
wiley   +1 more source

Regular Use of Ivermectin as Prophylaxis for COVID-19 Led Up to a 92% Reduction in COVID-19 Mortality Rate in a Dose-Response Manner: Results of a Prospective Observational Study of a Strictly Controlled Population of 88,012 Subjects [PDF]

, 2022
Lucy Kerr, Fernando Baldi, Raysildo Barbosa Lôbo, Washington Luiz O Assagra, Fernando Carlos Proença, Juan J Chamie, Jennifer A Hibberd, Pierre Kory, Flavio Cadegiani   +8 more
openalex   +1 more source

First documentation of in vivo and in vitro ivermectin resistance in Sarcoptes scabiei [PDF]

, 2004
Ivermectin is increasingly being used to treat scabies, especially crusted (Norwegian) scabies. However, treatment failures, recrudescence, and reinfection can occur, even after multiple doses.
Currie, Bart John, Harumal, P, McKinnon, M, Walton, Shelley F   +3 more
core   +1 more source

Effect of land use change on Melolonthidae (Coleoptera: Scarabaeoidea) beetle communities in the deforestation arc of the Brazilian Amazon

Insect Conservation and Diversity, EarlyView.
Habitat transformation in Amazon due to agriculture expansion impairs Melolonthidae diversity. Assemblage response towards habitat transformation are group‐dependent. Although highly disturbed, Amazon arc of deforestation region dwells sensitive insect assemblages. Abstract Although the Amazon provides crucial goods and ecosystem services for humanity,
Kleyton Rezende Ferreira, Elio Cesar Guzzo, Renato Portela Salomão, Fernando Zagury Vaz‐de‐Mello, César Murilo de Albuquerque Correa   +4 more
wiley   +1 more source

Lymphatic Filariasis Control in Tanzania: Effect of Six Rounds of Mass Drug Administration with Ivermectin and Albendazole on Infection and Transmission. [PDF]

, 2013
Control of lymphatic filariasis (LF) in most countries of sub-Saharan Africa is based on annual mass drug administration (MDA) with a combination of ivermectin and albendazole, in order to interrupt transmission. We present findings from a detailed study
C Chaccour, DJ Tisch, DW Meyrowitsch, DW Meyrowitsch, DW Meyrowitsch, E Michael, E Michael, E Michael, EM Pedersen, Erling M Pedersen, FO Richards, GJ Weil, GJ Weil, GJ Weil, H Joseph, HM Joseph, JD King, JE McMahon, JE McMahon, JL Liang, JM Mlandonicky, KC Kobylinski, KD Ramaiah, KY Won, LM Zeldenryk, M Parker, MN Malecela, Mwele N Malecela, N Kolstrup, O Mitja, Paul E Simonsen, PE Simonsen, PE Simonsen, PE Simonsen, PE Simonsen, PE Simonsen, PE Simonsen, PE Simonsen, PE Simonsen, PE Simonsen, PJ Hotez, RMR Ramzy, RT Rwegoshora, Stephen M Magesa, WHO, WHO, William N Kisinza, YA Derua, Yahya A Derua   +48 more
core   +1 more source

Efficacy and Safety of Ivermectin for Treatment and prophylaxis of COVID-19 Pandemic

, 2020
Background: Up-to-date, there is no recognized effective treatment or vaccine for the treatment of COVID-19 that emphasize urgency around distinctive effective therapies.
A. Elgazzar, A.I. Eltaweel, Shaimaa Abo Youssef, Basma Hany, Mohy Hafez, Hany Moussa   +5 more
semanticscholar   +1 more source

The exposomal imprint on rosacea: More than skin deep

Journal of the European Academy of Dermatology and Venereology, EarlyView.
Rosacea reflects systemic and environmental interactions, not just a skin disorder. Key factors include environmental triggers, genetic and microbiome influences, diagnostic gaps in skin of colour and social determinants. Advances in multi‐omics and exposome integration highlight pathways towards precision medicine, prevention and equitable, patient ...
Katerina Grafanaki, Daniella Bakoli Sgourou, Alexandros Maniatis, Efstathia Pasmatzi   +3 more
wiley   +1 more source